Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, the...
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
About this item
Full title
Author / Creator
Tian, Yu , Xiao, Haijuan , Yang, Yanhui , Zhang, Pingping , Yuan, Jiahui , Zhang, Wei , Chen, Lijie , Fan, Yibao , Zhang, Jinze , Cheng, Huan , Deng, Tingwei , Yang, Lin , Wang, Weiwei , Chen, Guoyong , Wang, Peiqin , Gong, Peng , Niu, Xing and Zhang, Xianbin
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Accumulated evidence highlights the significance of the crosstalk between epigenetic and epitranscriptomic mechanisms, notably 5-methylcytosine (5mC) and N.sup.6-methyladenosine (m.sup.6A). Herein, we conducted a widespread analysis regarding the crosstalk between 5mC and m.sup.6A regulators in hepatocellular carcinoma (HCC). Methods Pan...
Alternative Titles
Full title
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c2e61858c2a4469a8d5f8d24cd41ce37
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c2e61858c2a4469a8d5f8d24cd41ce37
Other Identifiers
ISSN
1476-4598
E-ISSN
1476-4598
DOI
10.1186/s12943-022-01706-6
